本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CNS Pharmaceuticals, Inc.

2.66
-0.0900-3.27%
盤後2.660.00000.00%16:20 EDT
成交量:2.29萬
成交額:6.18萬
市值:215.83萬
市盈率:-0.07
高:2.85
開:2.85
低:2.58
收:2.75
52周最高:34.80
52周最低:2.06
股本:81.14萬
流通股本:71.50萬
量比:0.57
換手率:3.20%
股息:- -
股息率:- -
每股收益(TTM):-35.7503
每股收益(LYR):-466.4490
淨資產收益率:-296.30%
總資產收益率:-115.35%
市淨率:0.48
市盈率(LYR):-0.01

資料載入中...

2020/03/26

重要事件披露

Current report, items 1.01 and 9.01
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/03/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 7.01 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/01/16

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/01/16

重要事件披露

Current report, items 7.01 and 9.01
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2019/12/20

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/22

重要事件披露

Current report, items 8.01 and 9.01
2019/11/14

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2019/11/05

SEC問詢函

[Cover]Correspondence
2019/11/05

SEC問詢函

[Cover]Correspondence
2019/10/15

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/10/10

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/10/07

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/22

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/16

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/16

SEC問詢函

[Cover]Correspondence
2019/07/16

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses